# Autologous Stem Cell Transplantation: International Lupus Trial

> **NCT05063513** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **European Society for Blood and Marrow Transplantation**

## Conditions studied

- REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

## Interventions

- **BIOLOGICAL:** Autologous Hematopoietic Stem Cell Transplantation
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT05063513
- **Lead sponsor:** European Society for Blood and Marrow Transplantation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-07
- **Primary completion:** 2013-07
- **Final completion:** 2017-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05063513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05063513, "Autologous Stem Cell Transplantation: International Lupus Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05063513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*